Spritz R A
Department of Medical Genetics, University of Wisconsin, Madison 53706, USA.
J Clin Immunol. 1998 Mar;18(2):97-105. doi: 10.1023/a:1023247215374.
Chediak-Higashi syndrome (CHS) is a rare, autosomal recessive, multisystem disorder in which severe immune deficits are accompanied by abnormalities of pigmentation, blood clotting, and neurologic function. There is no specific treatment, and without bone marrow transplantation, most patients succumb to frequent bacterial infections or to a lymphoproliferative syndrome that appears to result principally from lack of natural killer cell function. Disorders similar to human CHS occur in many mammalian species, the most important being the beige mouse, long considered a likely homologue of human CHS. This supposition has recently been confirmed by the mapping, cloning, and mutation analysis of the homologous human CHS1 and mouse beige genes. Identification of the human CHS1 gene, and the availability of a ready mouse model for human CHS, will likely facilitate investigation of the disease pathophysiology and the development of novel and specific treatments for the disorder.
切迪阿克-东综合征(CHS)是一种罕见的常染色体隐性多系统疾病,严重的免疫缺陷伴有色素沉着、血液凝固和神经功能异常。目前尚无特效治疗方法,若不进行骨髓移植,大多数患者会死于频繁的细菌感染或一种主要由自然杀伤细胞功能缺乏导致的淋巴增殖综合征。许多哺乳动物物种中都存在与人类CHS相似的疾病,其中最重要的是米色小鼠,长期以来一直被认为可能是人类CHS的同源物。最近,通过对同源的人类CHS1基因和小鼠米色基因进行定位、克隆和突变分析,这一推测得到了证实。人类CHS1基因的鉴定以及现成的人类CHS小鼠模型的可得性,可能会促进对该疾病病理生理学的研究以及开发针对该疾病的新型特效治疗方法。